Role of CD44 in tumour progression and strategies for targeting. - Wikidata - awgldk - TriplyDB

Role of CD44 in tumour progression and strategies for targeting.

Role of CD44 in tumour progression and strategies for targeting.

http://www.wikidata.org/entity/Q38023546

about

Therapies targeting cancer stem cells: Current trends and future challenges Hyaluronan and cardiac regeneration Collagen VI and hyaluronan: the common role in breast cancer Immunotargeting of cancer stem cells Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis Targeting Tumor Cells with Anti-CD44 Antibody Triggers Macrophage-Mediated Immune Modulatory Effects in a Cancer Xenograft Model CD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating Cells Cancer metastases: challenges and opportunities Incidental advanced-stage Hodgkin lymphoma diagnosed at the time of radical prostatectomy for prostatic cancer: a case report and review of literature.CD44 targets Wnt/β-catenin pathway to mediate the proliferation of K562 cells Dynamic changes of CD44 expression from progenitors to subpopulations of astrocytes and neurons in developing cerebellum A natural bacterial-derived product, the metalloprotease arazyme, inhibits metastatic murine melanoma by inducing MMP-8 cross-reactive antibodies.Coating Solid Lipid Nanoparticles with Hyaluronic Acid Enhances Antitumor Activity against Melanoma Stem-like Cells.Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression Sensitization of chemo-resistant human chronic myeloid leukemia stem-like cells to Hsp90 inhibitor by SIRT1 inhibition.Expression of cell adhesion molecule CD44 in mucoepidermoid carcinoma and its association with the tumor behavior.Renal Fibrosis mRNA Classifier: Validation in Experimental Lithium-Induced Interstitial Fibrosis in the Rat Kidney.Reduced cohesin destabilizes high-level gene amplification by disrupting pre-replication complex bindings in human cancers with chromosomal instability.Monoclonal antibodies against human cancer stem cells.Anti-CD44 mAb for the treatment of B-cell chronic lymphocytic leukemia and other hematological malignancies: evaluation of WO2013063498.The Role of CD44 in Disease Pathophysiology and Targeted Treatment.Deguelin inhibits the migration and invasion of lung cancer A549 and H460 cells via regulating actin cytoskeleton rearrangement.Prognostic value of CD44 expression in patients with hepatocellular carcinoma: meta-analysis.The ability of hyaluronan fragments to reverse the resistance of C6 rat glioma cell line to temozolomide and carmustine.Lipid-Based Nanovectors for Targeting of CD44-Overexpressing Tumor Cells.Cancer stem cell marker glycosylation: Nature, function and significance.Role of CD44 as a marker of cancer stem cells in head and neck cancer.Hyaluronic acid-conjugated liposome nanoparticles for targeted delivery to CD44 overexpressing glioblastoma cells.CD44v6-competent tumor exosomes promote motility, invasion and cancer-initiating cell marker expression in pancreatic and colorectal cancer cells.A caspase-3 'death-switch' in colorectal cancer cells for induced and synchronous tumor apoptosis in vitro and in vivo facilitates the development of minimally invasive cell death biomarkers Prioritization of candidate genes for periodontitis using multiple computational tools.CD44 induces FOXP3 expression and is related with favorable outcome in breast carcinoma.Advancing chemical risk assessment decision-making with population variability data: challenges and opportunities.Tunicamycin inhibits cell proliferation and migration in hepatocellular carcinoma via suppression of CD44s and the ERK1/2 pathway.CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance Prognostic Value of CD44 and Its Isoforms in Advanced Cancer: A Systematic Meta-Analysis With Trial Sequential Analysis

P2860

Q26777880-3A4E968E-24E7-45B0-A305-3ED1A5300370 Q26852190-5A3254BB-A15E-490D-8397-775902B7FA38 Q27011319-2CA5EBEC-2A08-4F94-BCA3-2A3C265C4B0B Q27014031-CD53F7F3-EC50-462A-BA7F-8B2F2E3998FF Q27023399-E04D61B7-78F0-4AD9-9C4D-9043F2BA9EAB Q27333471-6898941C-EA92-4D5A-9148-7402652CAA12 Q28084610-1BB8027B-DAD1-4395-938A-8A1D5889DD78 Q28088755-1182B56C-71AE-4CC3-9060-0EACEE1EE5E6 Q34123665-81D92CD6-AFD9-436B-91D6-73292EB01E18 Q34251497-E8E0E507-6BFE-4F92-9C27-6D7915B7EBE0 Q34544707-4C21ECB9-8AC0-42B1-90F1-588C6104362F Q35161541-FF98B144-C8F4-404B-85DC-F7691D00C9A9 Q35476018-6672C17A-3E5C-4C50-A59D-415E36F9894A Q35545627-6A6AC689-1619-4831-96CD-A588ABCDF293 Q35830047-C1AD5D9F-8B6F-43D1-B49C-AB0E8EAF612E Q35907460-2DCEC7E1-BC9A-43BB-9A4C-BA6B67B1BBEB Q36230543-CC7FE67C-12DA-4D16-BB6D-20A39C651611 Q36532727-060C4C66-B199-42C6-A2EE-F2E59EA96D3F Q38206818-838C53A0-0189-4647-AF10-3D843DB9D710 Q38209572-48612B9A-D17B-47C8-8C2D-2101146B729E Q38466771-7EC0D22C-5C09-4EC7-9322-292719E2F4F1 Q38793596-2D42A30B-70DA-41AB-B52C-4B905D78F83E Q38872768-643D92F7-8D91-4B6C-B2FB-5561BBF7E8F2 Q38932015-A2217A32-6513-4CF9-AEF8-710691499A89 Q39245886-B6F28672-96E1-4560-87B5-2B42BEE38938 Q39380552-58F54B8D-81AD-433E-BA05-9E6E78503294 Q41209219-971A5117-971F-492A-B290-7633516B86FE Q41610063-F43344DE-0C0D-4EDC-84ED-4CA6A4402238 Q41849010-F36FCF58-7E54-49C6-B16E-776D01F94633 Q42142229-188316C1-2ED4-4DA4-9489-E6A29D8C1AA4 Q42240245-BA6C4A7A-6CD4-4845-9ED4-9F59ED1E222A Q42502215-F5A1321A-4642-4AA6-BD7B-0B25F23B0B0A Q47211649-65627056-4D04-42D0-945A-AAB4809DC9A5 Q49609694-F3735C11-F845-49E7-9992-8ADA385532DD Q58697956-8D05B4AD-3AA9-4E91-97AE-8D77A9EC72F4 Q58850422-10B021A1-0CF3-434D-815E-DAB5B7EC961F Q61798737-f34d76b9-4ed4-20c0-e76f-da6bc90c2af5

P2860

Role of CD44 in tumour progression and strategies for targeting.

http://www.wikidata.org/entity/Q38023546

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Role of CD44 in tumour progression and strategies for targeting.

@en

type

label

Role of CD44 in tumour progression and strategies for targeting.

@en

prefLabel

Role of CD44 in tumour progression and strategies for targeting.

@en

P1433

Q38023546-6557525B-8ED2-48CD-AC61-F8056C5745C4

P1476

Q38023546-9DA44241-0771-4090-97DF-56846423960C

P2093

Q38023546-08FC279B-38EE-4EB5-B6D2-3114B1E8484B

Q38023546-1E3C52A7-BCE6-4A22-91BA-B59F415ADADF

Q38023546-8BA40D3B-BB27-4FA8-980D-69E936D38B49

Q38023546-9559A510-159C-4A06-AA63-EFC06009AC84

Q38023546-CB9EA7EC-AB1F-4B8D-B4A2-A47A4150C0F0

Q38023546-E5458782-0F9A-4101-BDD3-07FE4F0503C0

P2860

Q38023546-04EE3BB7-F926-4DAF-B491-23242F932B3E

Q38023546-059EE695-C574-40C1-87AF-BACE04F7037B

Q38023546-0930E3D0-C5A2-4F00-80EB-807FAEEEA228

Q38023546-11F6D193-86F1-4ADD-AC17-EBE7819A681D

Q38023546-192AE18B-58F5-4EC4-A09B-8F332E3E955F

Q38023546-1A521A4E-1E42-412C-AB3E-34387774E69D

Q38023546-1ACCB6E1-6EC0-4120-ACB5-D58401A3CACE

Q38023546-1E1FA5FB-0BA7-4919-AC50-B75B019F6B11

Q38023546-1EF4AE96-7CC1-4FB6-9501-A259193A7360

Q38023546-21633F53-BB14-40E2-B745-4C34F5282066

P304

Q38023546-C7516FD8-55BF-4375-90B5-5F98452108D1

P31

Q38023546-B6CE0C44-2F2E-49E1-8B32-FC3B22B7D95A

P356

Q38023546-70DF6A37-152E-459A-B064-F57FC2336E26

P433

Q38023546-9536BB9D-38E3-476D-AE8F-76CCBFC0202D

P478

Q38023546-D33D2033-E0DF-41DE-AD65-565810766D80

P577

Q38023546-AD59BEBF-39D8-4120-8AC8-6998DFF30475

P698

Q38023546-540A7B39-9F9E-422F-BEBA-2FE9D750DECD

P356

1061186X.2012.702767

P1433

Journal of Drug Targeting

P1476

Role of CD44 in tumour progression and strategies for targeting.

@en

P2093

Farhan J Ahmad

http://www.w3.org/2001/XMLSchema#string

Lalit Mohan Negi

http://www.w3.org/2001/XMLSchema#string

Manu Jaggi

http://www.w3.org/2001/XMLSchema#string

Roop K Khar

http://www.w3.org/2001/XMLSchema#string

Sushama Talegaonkar

http://www.w3.org/2001/XMLSchema#string

Zeenat Iqbal

http://www.w3.org/2001/XMLSchema#string

P2860

The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells

Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin

Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis

A phase I dose escalation study with anti-CD44v6 bivatuzumab mertansine in patients with incurable squamous cell carcinoma of the head and neck or esophagus

Heparan sulphate proteoglycans fine-tune mammalian physiology

Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy.

Cancer cell specific targeting of nanogels from acetylated hyaluronic acid with low molecular weight.

Non-invasive detection of bladder cancer by identification of abnormal CD44 proteins in exfoliated cancer cells in urine.

Lateral interactions among membrane proteins. Implications for the organization of gap junctions

Combinatorial selection of DNA thioaptamers targeted to the HA binding domain of human CD44

P304

561-573

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/1061186X.2012.702767

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22758394

http://www.w3.org/2001/XMLSchema#string